| Title |
Management of HIV/AIDS in older patients–drug/drug interactions and adherence to antiretroviral therapy
|
|---|---|
| Published in |
HIV/AIDS (Auckland, N.Z.), October 2015
|
| DOI | 10.2147/hiv.s39655 |
| Pubmed ID | |
| Authors |
Mary J Burgess, John D Zeuli, Mary J Kasten |
| Abstract |
Patients with human immunodeficiency virus (HIV) are living longer with their disease, as HIV has become a chronic illness managed with combination antiretroviral therapy (cART). This has led to an increasing number of patients greater than 50 years old living successfully with HIV. As the number of older adults with HIV has increased, there are special considerations for the management of HIV. Older adults with HIV must be monitored for drug side effects and toxicities. Their other non-HIV comorbidities should also be considered when choosing a cART regimen. Older adults with HIV have unique issues related to medication compliance. They are more likely than the younger HIV patients to have vision loss, cognitive impairment, and polypharmacy. They may have lower expectations of their overall health status. Depression and financial concerns, especially if they are on a fixed income, may also contribute to noncompliance in the aging HIV population. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Colombia | 1 | <1% |
| Unknown | 164 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 33 | 20% |
| Researcher | 16 | 10% |
| Student > Bachelor | 15 | 9% |
| Student > Ph. D. Student | 13 | 8% |
| Student > Postgraduate | 11 | 7% |
| Other | 35 | 21% |
| Unknown | 43 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 55 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 8% |
| Nursing and Health Professions | 12 | 7% |
| Social Sciences | 7 | 4% |
| Immunology and Microbiology | 5 | 3% |
| Other | 18 | 11% |
| Unknown | 55 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2019.
All research outputs
#8,039,503
of 25,584,565 outputs
Outputs from HIV/AIDS (Auckland, N.Z.)
#73
of 330 outputs
Outputs of similar age
#90,102
of 287,342 outputs
Outputs of similar age from HIV/AIDS (Auckland, N.Z.)
#3
of 4 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 330 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,342 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.